Matches in Nanopublications for { ?s ?p "[The methylation profiles of lobular vs. ductal carcinomas with respect to RASSF1A, Cyclin D2, RARbeta, and Hin-1 genes were similar, suggesting that gene silencing by promoter hypermethylation is likely to be important in both groups of diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[The methylation profiles of lobular vs. ductal carcinomas with respect to RASSF1A, Cyclin D2, RARbeta, and Hin-1 genes were similar, suggesting that gene silencing by promoter hypermethylation is likely to be important in both groups of diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP862241.RAh0kPY06JGZLmuDN6HKV89ZrNgSLZc5LP1Pm69eeOZAw130_assertion description "[The methylation profiles of lobular vs. ductal carcinomas with respect to RASSF1A, Cyclin D2, RARbeta, and Hin-1 genes were similar, suggesting that gene silencing by promoter hypermethylation is likely to be important in both groups of diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862241.RAh0kPY06JGZLmuDN6HKV89ZrNgSLZc5LP1Pm69eeOZAw130_provenance.
- NP419396.RAZlyhcsUmKK-Zre4Z5v9-_dMFMavkEKaJ16ySGHBA5nM130_assertion description "[The methylation profiles of lobular vs. ductal carcinomas with respect to RASSF1A, Cyclin D2, RARbeta, and Hin-1 genes were similar, suggesting that gene silencing by promoter hypermethylation is likely to be important in both groups of diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419396.RAZlyhcsUmKK-Zre4Z5v9-_dMFMavkEKaJ16ySGHBA5nM130_provenance.